Clinical Trial Update: AblaView® Unipolar PFA OCR-guided Feasibility Study - First in Man [NA]

View source ↗

Summary

First-in-man feasibility study of the AblaView Unipolar PFA OCR-guided device for paroxysmal atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Drugs mentioned

• AblaView

Snippet

Sponsor: Medlumics | Conditions: Paroxysmal AF | NA | Status: COMPLETED